The Association of Cardio-Ankle Vascular Index and Ankle-Brachial Index with Macroangiopathy in Patients with Type 2 Diabetes Mellitus

por Niwa, Hirokatsu, Takahashi, Kiyohiko, Dannoura, Midori, Oomori, Kazuno, Miyoshi, Arina, Inada, Toshihiro, Miyoshi, Hideaki
Publicado 2019

Initial dip predicts renal protective effects after the administration of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and chronic kidney disease with...

por Takahashi, Kiyohiko, Nakamura, Akinobu, Furusawa, Sho, Yokozeki, Kei, Sugawara, Hajime, Yanagisawa, Hideyuki, Akikawa, Kazumasa, Kikuchi, Hideaki
Publicado 2020

Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages

por Takahashi, Kiyohiko, Nakamura, Akinobu, Miyoshi, Hideaki, Nomoto, Hiroshi, Kitao, Naoyuki, Omori, Kazuno, Yamamoto, Kohei, Cho, Kyu Yong, Terauchi, Yasuo, Atsumi, Tatsuya
Publicado 2018

SAT-413 Does Dipeptidyl Peptidase-4 Inhibitor Exacerbate Graves’ Disease?

por Sekizaki, Tomonori, Kameda, Hiraku, Cho, Kyu Yong, Akinobu, Nakamura, Takahashi, Kiyohiko, Wada, Norio, Takeuchi, Jun, Nagai, So, Miyoshi, Hideaki, Atsumi, Tatsuya
Publicado 2020

Dipeptidyl peptidase‐4 inhibitor might exacerbate Graves’ disease: A multicenter observational case–control study

por Sekizaki, Tomonori, Kameda, Hiraku, Nomoto, Hiroshi, Cho, Kyu Yong, Nakamura, Akinobu, Takahashi, Kiyohiko, Miyoshi, Arina, Wada, Norio, Takeuchi, Jun, Nagai, So, Miyoshi, Hideaki, Atsumi, Tatsuya
Publicado 2021

SAT-073 A Case of Williams Syndrome Associated with Aldosterone Producing Adrenal Adenoma Mimicking Hepatic Adrenal Rest Tumor

por Wada, Norio, Baba, Shuhei, Takahashi, Kiyohiko, Miyoshi, Arina, Obara, Shinji, Takahashi, Bunya, Usubuchi, Hiroaki, Terae, Satoshi, Sunahara, Masao, Oshima, Takahiro, Misawa, Kazuhito, Yamazaki, Yuto, Sasano, Hironobu
Publicado 2019

Glucokinase is required for high‐starch diet‐induced β‐cell mass expansion in mice

por Tsuchida, Kazuhisa, Nakamura, Akinobu, Miyoshi, Hideaki, Yang, Kelaier, Yamauchi, Yuki, Kawata, Shinichiro, Omori, Kazuno, Takahashi, Kiyohiko, Kitao, Naoyuki, Nomoto, Hiroshi, Kameda, Hiraku, Cho, Kyu Yong, Seino, Yusuke, Terauchi, Yasuo, Atsumi, Tatsuya
Publicado 2021

Luseogliflozin preserves the pancreatic beta-cell mass and function in db/db mice by improving mitochondrial function

por Yamauchi, Yuki, Nakamura, Akinobu, Yokota, Takashi, Takahashi, Kiyohiko, Kawata, Shinichiro, Tsuchida, Kazuhisa, Omori, Kazuno, Nomoto, Hiroshi, Kameda, Hiraku, Cho, Kyu Yong, Anzai, Toshihisa, Tanaka, Shinya, Terauchi, Yasuo, Miyoshi, Hideaki, Atsumi, Tatsuya
Publicado 2022

Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes

por Takahashi, Kiyohiko, Cho, Kyu Yong, Nakamura, Akinobu, Miya, Aika, Miyoshi, Arina, Yamamoto, Chiho, Nomoto, Hiroshi, Niwa, Hirokatsu, Takahashi, Kiyohito, Manda, Naoki, Kurihara, Yoshio, Aoki, Shin, Ito, Yoichi M, Atsumi, Tatsuya, Miyoshi, Hideaki
Publicado 2018